Marathon Capital Management »

Aziyo Biologics shares owned by Marathon Capital Management

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Marathon Capital Management from 13F filings

Historical chart of Marathon Capital Management investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Marathon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Marathon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.8k 10k 0.98

More positions owned by Marathon Capital Management

T. Rowe Price (TROW)
Corning Incorporated (GLW)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Apple (AAPL)
Astrazeneca Ord (AZN)
TETRA Technologies (TTI)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Zscaler Incorporated (ZS)
Microsoft Corporation (MSFT)
International Business Machines (IBM)
MetLife (MET)
CECO Environmental (CECO)
Almonty Inds Com New (ALM)

View all positions for Marathon Capital Management

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Knollwood Investment Advisory
Silverarc Capital Management
Vanguard Capital Management
Perkins Capital Management
Geode Capital Management
CI Private Wealth
Renaissance Technologies
Vanguard Fiduciary Trust
BlackRock
Birchview Capital
Citadel Advisors
Rossmore Private Capital
GSA Capital Partners

View all funds holding Aziyo Biologics